France – Équipements médicaux – FOURNITURE DE SEPARATEURS D’APHERESE POUR LA PRODUCTION DE CONCENTRE PLAQUETTAIRE D’APHERESE DESTINE A LA VIRO ATTENUATION ET PLASMA SECONDAIRE, DMU ET PRESTATIONS ASSOCIEES

DeadlineAugust 28, 2026 at 09:59 PM44 days left

AI summary

This tender concerns the supply of apheresis separators for producing platelet concentrate through apheresis, intended for viral attenuation and secondary plasma production, including equipment, consumables, and associated services. The French Blood Establishment seeks a comprehensive solution for blood component separation and processing.

#medical devices#apheresis#blood products#france#platelet concentrate#healthcare equipment
Fit for

Medical device manufacturers or authorized distributors specializing in apheresis technology and blood component separation equipment should bid. Experience in supplying blood establishments and regulatory compliance in medical device manufacturing is essential.

Key requirements

Suppliers must provide apheresis separator equipment capable of producing platelet concentrates for viral attenuation and plasma applications. Technical compliance with French blood service standards, regulatory approval, and capacity to deliver consumables and maintenance services are required.

Frequently asked questions

  • What is this tender about?

    This tender concerns the supply of apheresis separators for producing platelet concentrate through apheresis, intended for viral attenuation and secondary plasma production, including equipment, consumables, and associated services. The French Blood Establishment seeks a comprehensive solution for blood component separation and processing.

  • What are the requirements for suppliers?

    Suppliers must provide apheresis separator equipment capable of producing platelet concentrates for viral attenuation and plasma applications. Technical compliance with French blood service standards, regulatory approval, and capacity to deliver consumables and maintenance services are required.

  • What type of company should bid?

    Medical device manufacturers or authorized distributors specializing in apheresis technology and blood component separation equipment should bid. Experience in supplying blood establishments and regulatory compliance in medical device manufacturing is essential.

  • Who is the buyer?

    The buyer is Etablissement français du sang.

  • When does this tender close?

    Submissions close on August 28, 2026.

  • What is the estimated value?

    The estimated value is 9,777,408 EUR.

FOURNITURE DE SEPARATEURS D’APHERESE POUR LA PRODUCTION DE CONCENTRE PLAQUETTAIRE D’APHERESE DESTINE A LA VIRO ATTENUATION ET PLASMA SECONDAIRE, DMU ET PRESTATIONS ASSOCIEES

Buyer
Etablissement français du sang
Buyer ID: 42882285202140·Direction des achats, de l'immobilier et de la maintenance
20 avenue du Stade de France, 93210, Saint-denis
Body responsible for review procedures
Tribunal Administratif de Montreuil
Buyer ID: 1300068690015·Greffe du tribunal administratif de montreuil
7 rue Catherine PUIG, 93100, Montreuil

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…